SCHEMBL26415609

SCHEMBL26415609

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5oc6cc(-c7ccc(N(c8ccccc8)c8ccccc8)cc7)ccc6c45)c4ccccc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MMP12 P39900 1/20 0.31
MMP13 P45452 1/20 0.31
KDM1A O60341 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25057647 0.96 TDP1 (0.32) ABCG2KDM4EALDH1A1MAPTHPGD
SCHEMBL25975513 0.93 HCRTR1 (0.35) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL26415577 0.93 TSHR (0.32) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL26415564 0.93 TSHR (0.32) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL24255609 0.93 TSHR (0.32) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL25975511 0.93 TSHR (0.32) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL26415673 0.93 MEN1 (0.33) HCRTR1KDM4EALDH1A1MAPTHPGD
SCHEMBL24255692 0.93 ALDH1A1 (0.38) HCRTR1ABCG2KDM4EALDH1A1MAPT
SCHEMBL25975498 0.92 MAPT (0.33) HCRTR1KDM4EALDH1A1MAPTHPGD
SCHEMBL23822410 0.92 ALDH1A1 (0.36) HCRTR1KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 HCRTR1 540/4885ABCG2 2795/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.